I received an email this afternoon from Locust W
Post# of 72440
Following our COVID-19 thought leadership piece on the strategic implications for biopharma, our panelists look forward to taking a deeper dive in the following:
Lessons for biopharma from the 2001 and 2008 financial crisis
Biopharma strategy in this turbulent financial environment
Capital markets turmoil and how to navigate
Venture capital landscape for new funding
Strategic dealmaking anticipated trends
Introducing our panelists (from left to right):
Geoff Meyerson, CEO & Co-Founder, Locust Walk
Chris Ehrlich, Senior Managing Director, Global Head of Biopharma, Locust Walk
Brian Coleman, Managing Director, Global Head of Financing and Sales, Locust Walk
Timothy Ehrlich, Partner, Gunderson Dettmer
Here is the link to register for webinar :
https://register.gotowebinar.com/register/470...0d3a5a72c7